Not applicableUnknownNCT03089411What this trial is testingCollection of Additional Data Followed the Study IFM 2013-04Who this might be right forMyeloma Multiple Nantes University Hospital 340
Large-scale testing (Phase 3)Active Not RecruitingNCT04027309What this trial is testingGilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive ChemotherapyWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts-2 Stichting Hemato-Oncologie voor Volwassenen Nederland 777
Not applicableUnknownNCT04115787What this trial is testingConservative Management in Patients Diagnosed With Grade 2 or Grade 3 CINWho this might be right forHigh-Grade Squamous Intraepithelial LesionsNeoplasm Regression, SpontaneousDisease Progression+1 more Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 104
Not applicableStudy completedNCT07084181What this trial is testingFitbit Assessed PS in Colorectal CancerWho this might be right forColorectal Cancer (Diagnosis) Fox Chase Cancer Center 80
Not applicableStudy completedNCT05549687What this trial is testingE-Health Support Program (PACK Health Program) in Supporting Patient Reported Symptoms in Newly Diagnosed Patients With Breast CancerWho this might be right forBreast Carcinoma M.D. Anderson Cancer Center 419
Not applicableStudy completedNCT04647981What this trial is testingDiagnostic Performance Evaluation Study of the Xpert® Bladder Cancer Monitor Test.Who this might be right forNon-Invasive Bladder Urothelial CarcinomaNon-Invasive Bladder Papillary Urothelial Carcinoma, Low GradeNon-Invasive Bladder Papillary Urothelial Carcinoma, High Grade Clinique Beau Soleil 320
Early research (Phase 1)Study completedNCT01089998What this trial is testingPET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With InflammationsWho this might be right forDiagnostic Imaging Lantheus Biosciences Ltd. 35
Not applicableUnknownNCT04778800What this trial is testingA Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)Who this might be right forNSCLCBrain MetastasesLeptomeningeal Metastasis Henan Cancer Hospital 60
Not applicableStudy completedNCT04498611What this trial is testingPrediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle BiopsyWho this might be right forCarcinoma, Ductal, BreastInvasive Breast CancerIMAGE Seoul National University Hospital 113
Testing effectiveness (Phase 2)Study completedNCT01782963What this trial is testingLenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)Who this might be right forMultiple Myeloma Massachusetts General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT01220271What this trial is testingA Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant GliomaWho this might be right forGlioma Eli Lilly and Company 75
Early research (Phase 1)Ended earlyNCT01950195What this trial is testingSRS (Stereotactic Radiosurgery) Plus IpilimumabWho this might be right forNewly Diagnosed Melanoma Metastases in the Brain and Spine Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Testing effectiveness (Phase 2)Study completedNCT01979536What this trial is testingBrentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell LymphomaWho this might be right forAnaplastic Large Cell Lymphoma, ALK-PositiveAnn Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell LymphomaAnn Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma+1 more National Cancer Institute (NCI) 137
Early research (Phase 1)Looking for participantsNCT04903795What this trial is testingBRiTE - Bispecific T Cell Engager for Patients With GlioblastomaWho this might be right forNewly Diagnosed GlioblastomaRecurrent Glioblastoma Mustafa Khasraw, MBChB, MD, FRCP, FRACP 18
Not applicableWithdrawnNCT04218019What this trial is testingEffect of Timing of Tumor-Treating Fields Plus Short-Course RadiationWho this might be right forNewly Diagnosed Glioblastoma in Patients ≥70 Years Juergen Debus
Early research (Phase 1)Looking for participantsNCT06651866What this trial is testingDose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML PatientsWho this might be right forAcute Myeloid Leukemia The First Affiliated Hospital of Xiamen University 18
Early research (Phase 1)Active Not RecruitingNCT04850495What this trial is testingZanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-Cell LymphomaTransformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaTransformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma Yazeed Sawalha 38
Not applicableStudy completedNCT00748319What this trial is testingKiller Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell LymphomaWho this might be right forMycosis FungicidesSezary SyndromeDermatitis+1 more Assistance Publique - Hôpitaux de Paris 495
Not applicableActive Not RecruitingNCT03968315What this trial is testingAn Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent ThymomaWho this might be right forRecurrent Malignant ThymomaThymoma M.D. Anderson Cancer Center 40
Not applicableStudy completedNCT03421626What this trial is testingClinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)Who this might be right forLeukemia, Myelogenous, Chronic Cepheid 266